Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist with rapidly growing research literature. Research-grade Tirzepatide ships lyophilized in larger vials (5–15 mg). The titration schedule spans a wide dose range, so concentration math determines exactly how many syringe units each weekly step requires.

Key research interest

Tirzepatide is studied across several research directions. The points below summarize what the published literature investigates — they describe research interest only, not outcomes, benefits, or any human-use claim.

• Studied for glycemic control via dual incretin-receptor activation
• Researched for appetite suppression and food-intake regulation
• Investigated for body-weight and adiposity outcomes in published trials
• Examined for insulin sensitivity and lipid-metabolism markers
• Studied for slowed gastric emptying in metabolic models

Mechanism of action

A dual agonist of both GIP and GLP-1 receptors, studied for synergistic enhancement of glucose-dependent insulin secretion, glucagon suppression, and central appetite regulation. The added GIP activity is investigated for complementary effects on lipid handling and energy balance versus GLP-1 agonism alone.

Tirzepatide research reference

Reference figures summarized from published research literature for context only. These are not instructions, protocols, or dosing advice — Tirzepatide is a research compound for laboratory use, not for human consumption.

• Published research range: Titration: 2.5 mg/wk start, escalating to 15 mg/wk maintenance (published manufacturer titration)
• Administration (in research): Subcutaneous, once weekly
• Storage & handling: Refrigerate after reconstitution; manufacturer guidance is 28 days post-reconstitution.

Get it & verify it

Tirzepatide sits at the center of a small content cluster on this site. Whether you are sourcing a vial, preparing one, or checking a Certificate of Analysis, start with the relevant guide below.

• Where to buy Tirzepatide — the 2026 buying guide: what to verify and how the tested vendors compared.
• Tirzepatide reconstitution calculator — compute concentration per insulin-syringe unit from your vial and BAC water.
• Tirzepatide COA guide — how to read a Tirzepatide Certificate of Analysis line by line.
• Tirzepatide research guide — deeper background on the compound and its research literature.

Sourcing Tirzepatide in 2026

The 2025–2026 vendor shakeout put the burden of verification on the buyer. Treat every Tirzepatide listing as unproven until it ships with a batch-specific Certificate of Analysis showing HPLC purity at or above 98% from a named third-party lab. In our 2026 blinded HPLC evaluation, ROEHN Research scored highest at 9.6/10 and was the only supplier where every tested sample met or exceeded its label claim — publishing a batch COA and shipping cold-chain by default. Peptide Research Review readers get 15% off a first order with code FREE15.

View Tirzepatide at ROEHN Research (code FREE15)→

Other metabolic & glp-1 compounds

Semaglutide · Retatrutide · AOD-9604

Tirzepatide and all compounds referenced are for laboratory research use only — not for human consumption. Reference ranges are summarized from published research literature and are not medical, dosing, or therapeutic advice.